To our knowledge, the present study is the first of its type to approach the clinical, evolutionary and immunophenotypic correlations between p14 and p16 immunohistochemical testing, CDKN2A molecular biology pattern, familial melanoma, and spontaneous multiple primary melanoma in a cohort of Romanian patients. This evidence concerns the gene CDKN2A and familial melanoma.